GSK plc
GLAXF · OTC
10/28/2025 | 9/30/2025 | 6/30/2025 | 3/31/2025 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,714 | – | $1,646 | $1,772 |
| Dep. & Amort. | $995 | – | $1,159 | $823 |
| Deferred Tax | $0 | – | $0 | $0 |
| Stock-Based Comp. | $0 | – | $0 | $0 |
| Change in WC | -$1,067 | – | -$1,031 | -$788 |
| Other Non-Cash | $385 | – | $322 | -$662 |
| Operating Cash Flow | $3,028 | – | $2,096 | $1,145 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,203 | – | -$256 | -$208 |
| Net Acquisitions | -$1,154 | – | -$36 | -$826 |
| Inv. Purchases | -$11 | – | $0 | $0 |
| Inv. Sales/Matur. | $174 | – | $0 | $0 |
| Other Inv. Act. | $44 | – | -$333 | -$110 |
| Investing Cash Flow | -$2,150 | – | -$625 | -$1,144 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$79 | – | -$874 | $1,918 |
| Stock Issued | $0 | – | $2 | $12 |
| Stock Repurch. | -$448 | – | -$561 | -$247 |
| Dividends Paid | -$905 | – | -$656 | -$612 |
| Other Fin. Act. | -$275 | – | -$283 | -$213 |
| Financing Cash Flow | -$1,707 | – | -$2,372 | $858 |
| Forex Effect | $335 | – | -$26 | -$11 |
| Net Chg. in Cash | -$495 | – | -$927 | $848 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $4,932 | – | $4,251 | $3,403 |
| End Cash | $4,437 | – | $3,324 | $4,251 |
| Free Cash Flow | $2,599 | – | $1,463 | $697 |